We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $72.6B
1-Year Est. Return 54.88%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+12.02%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.93%
AUM
$64.6B
AUM Growth
+$5.95B
Cap. Flow
+$299M
Cap. Flow %
0.46%
Top 10 Hldgs %
11.91%
Holding
4,318
New
702
Increased
1,590
Reduced
1,355
Closed
633

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$653M
2
AMZN icon
Amazon
AMZN
+$602M
3
XOM icon
ExxonMobil
XOM
+$473M
4
TSLA icon
Tesla
TSLA
+$437M
5
SBUX icon
Starbucks
SBUX
+$380M

Sector Composition

Rank Sector Weight
1 Technology 19.68%
2 Healthcare 17.69%
3 Consumer Discretionary 13.09%
4 Industrials 7.96%
5 Consumer Staples 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUBN icon
3026
Auburn National Bancorp
AUBN
$91.6M
$269K ﹤0.01%
12,641
+3,100
+32% +$64.7K
EDN
3027
Edenor
EDN
$1.01B
$269K ﹤0.01%
13,900
-28,200
-67% -$400K
BRAG
3028
Bragg Gaming Group
BRAG
$46.9M
$268K ﹤0.01%
53,095
+28,495
+116% +$138K
IYY icon
3029
iShares Dow Jones US ETF
IYY
$3.09B
$268K ﹤0.01%
2,300
-1,100
-32% -$120K
PXS icon
3030
Pyxis Tankers
PXS
$52M
$268K ﹤0.01%
64,317
-23,584
-27% -$92.5K
SGHC icon
3031
SGHC Ltd
SGHC
$6.7B
$268K ﹤0.01%
+84,600
New +$284K
ESCA icon
3032
Escalade
ESCA
$277M
$266K ﹤0.01%
13,230
+1,500
+13% +$27.7K
RNST icon
3033
Renasant Corp
RNST
$3.98B
$266K ﹤0.01%
7,900
-120,328
-94% -$3.37M
EVI icon
3034
EVI Industries
EVI
$218M
$265K ﹤0.01%
+11,165
New +$282K
FHLC icon
3035
Fidelity MSCI Health Care Index ETF
FHLC
$3.4B
$265K ﹤0.01%
+4,100
New +$250K
LSTA icon
3036
Lisata Therapeutics
LSTA
$10.4M
$265K ﹤0.01%
97,222
+1,500
+2% +$3.52K
SCPH
3037
DELISTED
scPharmaceuticals
SCPH
$263K ﹤0.01%
+41,900
New +$240K
MNOV icon
3038
MediciNova
MNOV
$64.5M
$261K ﹤0.01%
174,100
+24,500
+16% +$44.3K
OBE
3039
Obsidian Energy
OBE
$713M
$261K ﹤0.01%
38,300
+22,600
+144% +$174K
BHM icon
3040
Bluerock Homes Trust
BHM
$36.4M
$260K ﹤0.01%
+18,600
New +$260K
JRSH icon
3041
Jerash Holdings
JRSH
$68.3M
$258K ﹤0.01%
82,940
+6,700
+9% +$20.3K
OCFT
3042
DELISTED
OneConnect Financial Technology
OCFT
$258K ﹤0.01%
79,960
+300
+0.4% +$912
GPGI
3043
GPGI Inc
GPGI
$3.68B
$257K ﹤0.01%
57,190
-22,635
-28% -$106K
CPSH icon
3044
CPS Technologies
CPSH
$84.7M
$256K ﹤0.01%
108,858
+19,675
+22% +$48.8K
LTBR icon
3045
Lightbridge
LTBR
$319M
$256K ﹤0.01%
+79,600
New +$317K
PNRG icon
3046
PrimeEnergy Resources
PNRG
$318M
$255K ﹤0.01%
2,400
VSTM icon
3047
Verastem
VSTM
$589M
$255K ﹤0.01%
31,365
-15,000
-32% -$108K
PICK icon
3048
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.28B
$254K ﹤0.01%
+5,900
New +$235K
AURA icon
3049
Aura Biosciences
AURA
$792M
$253K ﹤0.01%
28,500
+15,000
+111% +$127K
CMTL icon
3050
Comtech Telecommunications
CMTL
$53M
$253K ﹤0.01%
30,050
-76,200
-72% -$795K

Similar funds

Jim Simons's Q4 2023 Portfolio in Review

As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
  • Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
  • Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
  • Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
  • Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
  • Jim Simons opened 702 new positions and closed 633 in Q4 2023.
  • Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.

Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.